Boyko Kabakchiev

982 total citations
34 papers, 673 citations indexed

About

Boyko Kabakchiev is a scholar working on Genetics, Epidemiology and Surgery. According to data from OpenAlex, Boyko Kabakchiev has authored 34 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Genetics, 20 papers in Epidemiology and 13 papers in Surgery. Recurrent topics in Boyko Kabakchiev's work include Inflammatory Bowel Disease (29 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (5 papers). Boyko Kabakchiev is often cited by papers focused on Inflammatory Bowel Disease (29 papers), Microscopic Colitis (19 papers) and Eosinophilic Esophagitis (5 papers). Boyko Kabakchiev collaborates with scholars based in Canada, United States and Israel. Boyko Kabakchiev's co-authors include Mark S. Silverberg, Raquel Milgrom, A. Hillary Steinhart, Andrea D. Tyler, Joanne M. Stempak, Kenneth Croitoru, Geoffrey C. Nguyen, Richard Kirsch, Orlaith Kelly and Eran Zittan and has published in prestigious journals such as Gastroenterology, PLoS ONE and Clinical Gastroenterology and Hepatology.

In The Last Decade

Boyko Kabakchiev

34 papers receiving 664 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boyko Kabakchiev Canada 14 378 278 237 128 114 34 673
Lígia Yukie Sassaki Brazil 12 259 0.7× 250 0.9× 189 0.8× 154 1.2× 68 0.6× 82 687
Kerri Glassner United States 7 440 1.2× 418 1.5× 314 1.3× 188 1.5× 123 1.1× 35 916
Shixian Hu China 14 185 0.5× 385 1.4× 121 0.5× 100 0.8× 98 0.9× 49 795
Klaus Kannengießer Germany 11 354 0.9× 119 0.4× 261 1.1× 192 1.5× 97 0.9× 19 675
Hedieh Balaii Iran 13 225 0.6× 206 0.7× 173 0.7× 100 0.8× 93 0.8× 35 570
A.H. Steinhart Canada 11 439 1.2× 155 0.6× 260 1.1× 229 1.8× 76 0.7× 19 690
Anja Schirbel Germany 14 292 0.8× 197 0.7× 187 0.8× 264 2.1× 237 2.1× 27 812
Ana Teresa Pugas Carvalho Brazil 12 231 0.6× 111 0.4× 168 0.7× 140 1.1× 137 1.2× 25 571
Lorenzo Zileri Dal Verme Italy 11 190 0.5× 286 1.0× 147 0.6× 144 1.1× 35 0.3× 28 595
Ιωάννα Αγγελετοπούλου Greece 16 99 0.3× 172 0.6× 213 0.9× 104 0.8× 94 0.8× 61 672

Countries citing papers authored by Boyko Kabakchiev

Since Specialization
Citations

This map shows the geographic impact of Boyko Kabakchiev's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boyko Kabakchiev with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boyko Kabakchiev more than expected).

Fields of papers citing papers by Boyko Kabakchiev

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boyko Kabakchiev. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boyko Kabakchiev. The network helps show where Boyko Kabakchiev may publish in the future.

Co-authorship network of co-authors of Boyko Kabakchiev

This figure shows the co-authorship network connecting the top 25 collaborators of Boyko Kabakchiev. A scholar is included among the top collaborators of Boyko Kabakchiev based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boyko Kabakchiev. Boyko Kabakchiev is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dorfman, Ruslan, et al.. (2020). Individualized Medication Management in Ontario Long-Term Care Clinical Impact on Management of Depression, Pain, and Dementia. Journal of the American Medical Directors Association. 21(6). 823–829.e5. 15 indexed citations
2.
Boland, Karen, Larbi Bedrani, Williams Turpin, et al.. (2020). Persistent Diarrhea in Patients With Crohn’s Disease After Mucosal Healing Is Associated With Lower Diversity of the Intestinal Microbiome and Increased Dysbiosis. Clinical Gastroenterology and Hepatology. 19(2). 296–304.e3. 25 indexed citations
3.
Sutcliffe, Simon, Shirin Kalyan, Darby Thompson, et al.. (2019). Novel Microbial-Based Immunotherapy Approach for Crohn's Disease. Frontiers in Medicine. 6. 170–170. 5 indexed citations
5.
Kevans, David, et al.. (2019). Histological Markers of Clinical Relapse in Endoscopically Quiescent Ulcerative Colitis. Inflammatory Bowel Diseases. 26(11). 1722–1729. 20 indexed citations
6.
Kabakchiev, Boyko, et al.. (2018). User considerations in assessing pharmacogenomic tests and their clinical support tools. npj Genomic Medicine. 3(1). 26–26. 40 indexed citations
7.
Zezos, Petros, Boyko Kabakchiev, Adam V. Weizman, et al.. (2018). Ulcerative Colitis Patients Continue to Improve Over the First Six Months of Vedolizumab Treatment: 12-Month Clinical and Mucosal Healing Effectiveness. Journal of the Canadian Association of Gastroenterology. 3(2). 74–82. 6 indexed citations
8.
Zittan, Eran, Boyko Kabakchiev, Orlaith Kelly, et al.. (2016). Development of the Harvey-Bradshaw Index-pro (HBI-PRO) Score to Assess Endoscopic Disease Activity in Crohn’s Disease. Journal of Crohn s and Colitis. 11(5). jjw200–jjw200. 31 indexed citations
9.
Zittan, Eran, Boyko Kabakchiev, Raquel Milgrom, et al.. (2016). Higher Adalimumab Drug Levels are Associated with Mucosal Healing in Patients with Crohn’s Disease. Journal of Crohn s and Colitis. 10(5). 510–515. 69 indexed citations
10.
Tyler, Andrea D., Richard Kirsch, Raquel Milgrom, et al.. (2016). Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype. Inflammatory Bowel Diseases. 22(4). 807–816. 20 indexed citations
12.
Kelly, Orlaith, et al.. (2016). Su1786 A PBMC-Derived microRNA Signature Differentiates Colonic Crohn's Disease from Ulcerative Colitis. Gastroenterology. 150(4). S550–S551. 1 indexed citations
13.
Morgan, Xochitl C., Boyko Kabakchiev, Levi Waldron, et al.. (2015). Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. Genome Biology. 16(1). 67–67. 143 indexed citations
14.
Kabakchiev, Boyko, Andrea D. Tyler, Joanne M. Stempak, Raquel Milgrom, & Mark S. Silverberg. (2014). Downregulation of Expression of Xenobiotic Efflux Genes is Associated with Pelvic Pouch Inflammation in Ulcerative Colitis. Inflammatory Bowel Diseases. 20(7). 1157–1164. 7 indexed citations
15.
Kevans, David, Boyko Kabakchiev, Judy Qiang, et al.. (2014). Sa1234 RNA-Seq Derived Whole Blood Gene Expression Signature As a Biomarker for Differential Diagnosis and Intestinal Inflammation in Inflammatory Bowel Disease. Gastroenterology. 146(5). S–238. 1 indexed citations
16.
Tyler, Andrea D., Natalie Knox, Boyko Kabakchiev, et al.. (2013). Characterization of the Gut-Associated Microbiome in Inflammatory Pouch Complications Following Ileal Pouch-Anal Anastomosis. PLoS ONE. 8(9). e66934–e66934. 73 indexed citations
17.
Kabakchiev, Boyko & Mark S. Silverberg. (2013). Expression Quantitative Trait Loci Analysis Identifies Associations Between Genotype and Gene Expression in Human Intestine. Gastroenterology. 144(7). 1488–1496.e3. 45 indexed citations
18.
Limbergen, Johan Van, Boyko Kabakchiev, Joanne M. Stempak, et al.. (2012). 97 Detailed Analysis of ATG16L1 Demonstrates Gene-Wide Extent of Association With Crohn's Disease Susceptibility. Gastroenterology. 142(5). S–23. 1 indexed citations
19.
Kabakchiev, Boyko, Dan Turner, Jeffrey S. Hyams, et al.. (2010). Gene Expression Changes Associated with Resistance to Intravenous Corticosteroid Therapy in Children with Severe Ulcerative Colitis. PLoS ONE. 5(9). e13085–e13085. 31 indexed citations
20.
Kabakchiev, Boyko, Smita Halder, & Mark S. Silverberg. (2009). The Future of Molecular Approaches to Inflammatory Bowel Disease. Molecular Diagnosis & Therapy. 13(4). 217–223. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026